Loading...
Not a good buy right now. SWK is trading near support (~78.25) and looks short-term oversold, but momentum is still deteriorating (bearish/expanding negative MACD) and insider selling has surged. With earnings on 2026-02-04 pre-market, the stock has a near-term catalyst but also headline risk; given the current downtrend/weak tape, the better edge is to wait for either (1) a clear rebound back above the ~81.29 pivot or (2) a post-earnings direction confirmation. Congress buying is a supportive longer-term signal, but it does not offset the near-term technical weakness and insider selling.
Price/levels: Post-market 78.61, sitting just above S1 (78.248). A clean break below S1 increases downside risk toward S2 (~76.37). Upside reclaim levels: pivot ~81.286 then R1 ~84.325.
Trend/momentum: MACD histogram -0.82 and negatively expanding = bearish momentum still strengthening. Moving averages are converging (indecision/transition), but momentum argues the stock has not confirmed a reversal yet.
RSI: RSI(6) ~29.3 = near oversold conditions, which can fuel a reflex bounce, but oversold alone is not a buy signal when MACD is still worsening.
Pattern-based forward odds: Model implies muted next-day (-0.02%) but modest upside skew over 1 week (+0.82%) and 1 month (+5.98%), suggesting a bounce is plausible if support holds.
Intellectia Proprietary Trading Signals

Latest reported quarter: 2025/Q3. Revenue was essentially flat (+0.13% YoY) at ~$3.756B, while profitability weakened sharply: net income -43.58% YoY to ~$51.4M and EPS -43.33% YoY to $0.34. The bright spot was gross margin, up to ~31.61 (+3.54% YoY), suggesting cost/mix improvements, but the earnings power has not yet followed through at the bottom line.
Recent changes are mixed but not collapsing: UBS kept Buy while cutting target to $98 (from $105) on 2026-01-05; Baird kept Neutral while raising target to $85 (from $75) on 2025-12-23 after the aerospace division sale; UBS previously raised to $105 on 2025-11-06. Wall Street pros: improving margin story, portfolio actions, and a path to better execution. Cons: earnings volatility/weakness and uneven demand keep some firms at Neutral and lead to target trims even among Bulls.